Event ·Multi-source

OpenAI 收购生物医药软件平台 Orchestra Bio

OpenAI 收购了生物医药软件平台 Orchestra Bio，交易金额未披露。OpenAI 指出，一款新药从发现到获得美国 FDA 批准平均需要 10 到 15 年。此次收购指向 OpenAI 将 AI 能力拓展到药物研发流程的意图。

Current read

OpenAI 把手伸进了制药行业，买下 Orchestra Bio。新药上市平均要 10 到 15 年，他们想用 AI 把这个流程压快。

11 sources57° AI heatLast updated 2026/10/21 06:21:20

Evidence

11 sources

Primary sourceTech in Asia

2026/10/21 06:21:20View source

Related source 1TestingCatalog

2026/10/20 18:21:43View source

Related source 2kimmonismus

2026/10/20 21:21:35View source

Related source 3IT之家

2026/10/20 22:51:11View source

Related source 4OpenAI Blog

2026/10/20 00:00:00View source

Related source 5rohanpaul_ai

2026/10/20 18:58:27View source

Related source 6Mark Chen (OpenAI 研究)

2026/10/20 19:33:08View source

Related source 7techcrunch

2026/10/20 20:35:10View source

Related source 8Nikkei Asia

2026/10/20 00:55:53View source

Related source 9Rest of World

2026/10/20 14:43:02View source

Related source 10Decoder

2026/10/21 08:32:54View source

Conflict check

Dedup data only shows that these sources discuss the same event, not that they agree. There is no structured supporting or refuting evidence yet, so no conflict is inferred automatically.

Open the story